Work

Protocol for CRISPR-Cas9 gene editing of murine neutrophils for in vitro and in vivo mechanistic studies

Year: 2026
Type: article
Abstract: Neutrophils’ short lifespan and resistance to genetic manipulation have limited mechanistic interrogation of gene-specific functions in these cells. Here, we present a protocol for gene targeting in murine neutrophil-lineage cells using two complementary CRISPR-Cas9-based strategies. First, we describe steps for an ER-Hoxb8-based system for scalable gain- and loss-of-function studies. We then detail procedures for a Lineage− Sca-1+ cKit+ (LSK) progenitor cell-based hematopoietic stem and progenitor cell-targeting strategy for stable genetic perturbation of endogenous neutrophils. For complete information on the generation and use of this protocol, please refer to Bolli et al. 1 1. Bolli, E. ∙ Wirapati, P. ∙ Hicham, M. ... CCL3 is produced by aged neutrophils across cancers and promotes tumor growth Cancer Cell. 2026; 44 :624-640.e12 Full Text Full Text (PDF) Scopus (8) PubMed Google Scholar
Language: English
Open Access status: gold
Estimated APC paid: $1,550
OpenAlex ID: W7234618452
FWCI:
Cites: 16
Cited by:
Related to: 10